Cholesterol goals established for patients with diabetes and metabolic syndrome.
Haffner
Steven M
SM
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000150:complications / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood / Q000592:standards*; D048909:Diabetes Complications; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D024821:Metabolic Syndrome; D017410:Practice Guidelines as Topic; D014481:United States
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors